FDA Reviewing Actos’s Safety
Posted by Admin | Posted in Medical Lawyers | Posted on 18-09-2010
The U.S. Food and Drug Administration has announced that it is reviewing safety data on the diabetes drug Actos (pioglitazone).
The U.S. Food and Drug Administration has announced that it is reviewing safety data on the diabetes drug Actos (pioglitazone).
Newest postings (August 25, 2010): Head of Science Collections and Scholarly Communication, University of Georgia (UGA) Libraries; Health Information QC Specialist, Frederick, MD. The MLANET job page is updated weekly on Wednesdays. Jobs appear chronologically, with the most recent postings at the top of the page, and then alphabetically by state. (Source: Medical Library Association News)
ADELPHI, Md.A Food and Drug Administration advisory on Sept. 16 panel voted 9-5 that the potential risks of the serotoninergic drug lorcaserin outweighed its potential benefits as a long-term treatment for weight loss in overweight and obese people and, therefore, did not support approval.
Pictured, left to right: Stephen Kiyoi, Julie Adamo, Salima M’seffar, Caitlin Sticco, Kristen Greenland, and Kristen Burgess.
Here at NN/LM PNR we are particularly pleased to announce the selection of this year’s Associate Fellows class because one of them, Kristen Greenland, graduated from University of Washington and did her Directed Fieldwork here in the Regional Medical Library Office! Kristen had a variety of experiences, including assisting with promoting and gathering information for the NLM’s Directory of History of Medicine Collections, working at the library’s Information Desk, and helping Dental students with a problem-based learning experience. A total of five Associate Fellows, plus one international Associate, will join NLM this fall to begin the y…
ADELPHI, Md. (EGMN) A Food and Drug Administration advisory panel split on whether to recommend that sibutramine be withdrawn from the market because of concerns over its cardiovascular safety.
SAN DIEGO (EGMN) Adults with decreased levels of serum 25-hydroxy vitamin D are significantly more likely to die from heart failure or die prematurely, compared with adults who have normal serum levels of vitamin D, results from a large analysis found.
Tune in at 12:00 pm Mountain Time/1:00 pm Central Time. **Note the starting time!
In this session, join Dana Abbey on an exploration of the My NCBI homepage interface and features of this time-saving tool. Learn to save, manage, and customize PubMed searches; create, share and edit your collections; and create bibliographies to save publications and manage compliance with the NIH Public Access Policy.
There will be hands on exercises to test the features of My NCBI, so if you don’t already have an account, please visit http://www.ncbi.nlm.nih.gov/sites/myncbi/register/ to register. For a handy MY NCBI tri-fold, visit http://nnlm.gov/training/resources/myncbitri.pdf.
Taking the one-hour class and completing the exercises and class evaluation makes you eligible to receive 1 Medical Lib…
PARIS (EGMN) Low-dose radioiodine ablation of 1.1 gigabecquerels (GBqs) is just as effective as the standard 3.7 GBq dose in eradicating thyroid remnants, with or without the concomitant use of recombinant human thyroid-stimulating hormone, in patients who have undergone thyroidectomy for differentiated thyroid cancer.
The Nursing and Allied Health Resources Section (NAHRS) seeks nominations for the NAHRS Award for Professional Excellence. This award recognizes a NAHRS member who exhibits outstanding leadership and exceptional librarianship in meeting the information needs of nursing and allied health professionals. The nomination may be made for service and contributions to the information needs of nursing and allied health professionals as demonstrated by excellence in leadership and librarianship, a history of professional publications, conference presentations and participation in NAHRS and MLA. The nominee must be a member of MLA and a member of the NAHRS Section.